NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹1,040 Cr | ₹911 Cr | ₹819 Cr | ₹803 Cr | ₹775 Cr |
What is the latest Total Non-Current Assets ratio of NEULAND LABORATORIES ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹1,040 Cr |
| Mar2024 | ₹911 Cr |
| Mar2023 | ₹819 Cr |
| Mar2022 | ₹803 Cr |
| Mar2021 | ₹775 Cr |
How is Total Non-Current Assets of NEULAND LABORATORIES Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,040 Cr | 14.14 | |
| Mar2024 | ₹911 Cr | 11.31 | |
| Mar2023 | ₹819 Cr | 2.01 | |
| Mar2022 | ₹803 Cr | 3.55 | |
| Mar2021 | ₹775 Cr | - | |
Compare Total Non-Current Assets of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹16,952.8 Cr | -4.7% | -13.6% | -1.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -4.7% |
-13.6% |
-1.6% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses